Literature DB >> 29468493

Facilitators and Barriers to Pre-Exposure Prophylaxis (PrEP) Use Among Black Individuals in the United States: Results from the National Survey on HIV in the Black Community (NSHBC).

Bisola O Ojikutu1,2, Laura M Bogart3, Molly Higgins-Biddle4, Sannisha K Dale5,6, Wanda Allen7, Tiffany Dominique8, Kenneth H Mayer9.   

Abstract

This study explores willingness to use PrEP among Black individuals in the US. From February to April 2016, an online survey was administered to a nationally representative sample of Black individuals. 855 individuals who were HIV negative by self-report participated [mean age: 33.6 (SD 9.2); 45.5% male]. Among all respondents, 14.5% were aware of, and 26.0% would be willing to use PrEP. Among high-risk individuals (N = 327), 19.8% knew about and 35.1% would be willing to use PrEP. The most common reason for lack of willingness among high-risk individuals was low self-perceived risk (65.1%). In multivariate analysis, individuals reporting single marital status [OR 1.8 (1.2, 2.5), p = 0.002], depressive symptoms [OR 1.6 (1.2, 2.2), p = 0.0054], arrest history [OR 1.7(1.2, 2.4), p = 0.0003], PrEP knowledge [OR 1.5 (1.0, 2.3), p = 0.0247] and belief in HIV conspiracies [OR 1.3 (1.1, 1.5), p = 0.0075] were more willing to use PrEP. Participants who saw a health care provider less frequently were less willing to use PrEP [OR 0.5 (0.4, 0.8), p = 0.0044]. Among a nationally representative sample of Black individuals, few high risk individuals were willing to use PrEP. Interventions to increase risk awareness, PrEP knowledge and access to care are necessary to improve PrEP uptake.

Entities:  

Keywords:  Black individuals in the US; HIV; HIV risk behavior; Pre-exposure prophylaxis

Mesh:

Year:  2018        PMID: 29468493      PMCID: PMC6103919          DOI: 10.1007/s10461-018-2067-8

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  46 in total

1.  Willingness to use pre-exposure prophylaxis among Black and White men who have sex with men in Atlanta, Georgia.

Authors:  Charlotte-Paige Rolle; Eli S Rosenberg; Nicole Luisi; Jeremy Grey; Travis Sanchez; Carlos Del Rio; John L Peterson; Paula M Frew; Patrick S Sullivan; Colleen F Kelley
Journal:  Int J STD AIDS       Date:  2016-10-20       Impact factor: 1.359

2.  Perceptions of lifetime risk and actual risk for acquiring HIV among young men who have sex with men.

Authors:  Duncan A MacKellar; Linda A Valleroy; Gina M Secura; Stephanie Behel; Trista Bingham; David D Celentano; Beryl A Koblin; Marlene LaLota; Douglas Shehan; Hanne Thiede; Lucia V Torian
Journal:  AIDS Behav       Date:  2007-03

3.  Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey.

Authors:  Judith Swan; Nancy Breen; Ralph J Coates; Barbara K Rimer; Nancy C Lee
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

4.  AIDS knowledge, perceived risk and prevention among adolescent clients of a family planning clinic.

Authors:  C S Weisman; C A Nathanson; M Ensminger; M A Teitelbaum; J C Robinson; S Plichta
Journal:  Fam Plann Perspect       Date:  1989 Sep-Oct

5.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

6.  Unprotected sex, underestimated risk, undiagnosed HIV and sexually transmitted diseases among men who have sex with men accessing testing services in a New England bathhouse.

Authors:  Kenneth H Mayer; Robert Ducharme; Nickolas D Zaller; Philip A Chan; Patricia Case; David Abbott; Irma I Rodriguez; Timothy Cavanaugh
Journal:  J Acquir Immune Defic Syndr       Date:  2012-02-01       Impact factor: 3.731

7.  Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education.

Authors:  Matthew J Mimiaga; Patricia Case; Carey V Johnson; Steven A Safren; Kenneth H Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

8.  Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among african american men with HIV.

Authors:  Laura M Bogart; Glenn Wagner; Frank H Galvan; Denedria Banks
Journal:  J Acquir Immune Defic Syndr       Date:  2010-04       Impact factor: 3.731

9.  Enhancing PrEP Access for Black and Latino Men Who Have Sex With Men.

Authors:  Corina Lelutiu-Weinberger; Sarit A Golub
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-15       Impact factor: 3.731

Review 10.  Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Michael Pignone; Melissa Rich; Steven M Teutsch; Alfred O Berg; Kathleen N Lohr
Journal:  Ann Intern Med       Date:  2002-07-16       Impact factor: 25.391

View more
  44 in total

1.  Intersectional social control: The roles of incarceration and police discrimination in psychological and HIV-related outcomes for Black sexual minority men.

Authors:  Devin English; Joseph A Carter; Lisa Bowleg; David J Malebranche; Ali J Talan; H Jonathon Rendina
Journal:  Soc Sci Med       Date:  2020-06-12       Impact factor: 4.634

2.  Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.

Authors:  Angela R Bazzi; Dea L Biancarelli; Ellen Childs; Mari-Lynn Drainoni; Alberto Edeza; Peter Salhaney; Matthew J Mimiaga; Katie B Biello
Journal:  AIDS Patient Care STDS       Date:  2018-10-11       Impact factor: 5.078

3.  Role of Social and Sexual Network Factors in PrEP Utilization Among YMSM and Transgender Women in Chicago.

Authors:  Gregory Phillips; Balint Neray; Michelle Birkett; Dylan Felt; Patrick Janulis; Brian Mustanski
Journal:  Prev Sci       Date:  2019-10

4.  Attitudes about community pharmacy access to HIV prevention medications in California.

Authors:  Kimberly A Koester; Parya Saberi; Shannon M Fuller; Emily A Arnold; Wayne T Steward
Journal:  J Am Pharm Assoc (2003)       Date:  2020-07-12

5.  Factors influencing pre-exposure prophylaxis uptake among current users: A qualitative study.

Authors:  Gloria Aidoo-Frimpong; Kennethea Wilson; Sarahmona Przybyla
Journal:  J HIV AIDS Soc Serv       Date:  2020-08-27

6.  Barriers and Facilitators to PrEP Use Among People Who Inject Drugs in Rural Appalachia: A Qualitative Study.

Authors:  Sean T Allen; Allison O'Rourke; Rebecca Hamilton White; Katherine C Smith; Brian Weir; Gregory M Lucas; Susan G Sherman; Suzanne M Grieb
Journal:  AIDS Behav       Date:  2020-06

7.  Correlates of PrEP Uptake Among Young Sexual Minority Men and Transgender Women in New York City: The Need to Reframe "Risk" Messaging and Normalize Preventative Health.

Authors:  J Jaiswal; C LoSchiavo; S Meanley; K Hascher; A B Cox; K B Dunlap; S N Singer; P N Halkitis
Journal:  AIDS Behav       Date:  2021-04-08

8.  Experiences of Pre-Exposure Prophylaxis (PrEP)-Related Stigma among Black MSM PrEP Users in Los Angeles.

Authors:  Ronald A Brooks; Omar Nieto; Amanda Landrian; Anne Fehrenbacher; Alejandra Cabral
Journal:  J Urban Health       Date:  2020-10       Impact factor: 3.671

9.  Pre-exposure Prophylaxis (PrEP) Awareness and Use Within High HIV Transmission Networks.

Authors:  Kellie Schueler; Matthew Ferreira; Georgios Nikolopoulos; Britt Skaathun; Dimitrios Paraskevis; Angelos Hatzakis; Samuel R Friedman; John A Schneider
Journal:  AIDS Behav       Date:  2019-07

10.  Hidden in Plain Sight: Identifying Women Living in the United States Who Could Benefit From HIV Preexposure Prophylaxis.

Authors:  B O Ojikutu; K H Mayer
Journal:  J Infect Dis       Date:  2020-10-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.